Jonathan Knowles By Natalie Morrison 21-Sep-2011 - Last updated on 22-Sep-2011 at 09:47 GMT Facebook Twitter Linkedin Email to a friend Once president of group research at Roche Holdings, Knowles now joins the board at Adaptimmune as a non-executive director.He joins the firm's current chief operating officer Helen Tayton-Martin, who will become executive director. Thomas Christély, CEO at Silence Therapeutics Gary Foulks, member InSite Vision's new scientific advisory board Kamran Hosseini leader of InSite Vision's new scientific advisory board Michael Lemp, member of InSite Vison's new scientific advisory board Brian Levy, helping to lead InSite Vision's new scientific advisory board Richard Lindstrom, member of InSite Vision's new scientific advisory board Kelly Nichols, member of InSite Vision's new scientific advisory board Dennis Kim, chief medical officer at Zafgen Helen Tayton-Martin, executive director at Adaptimmune Jonathan Knowles, non-executive board member at Adaptimmune Prev 1 … 6 7 8 9 10 Next